Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation.

× No keyword cloud information.

26 in total

1. Intense [18F]FDG tongue uptake in a case of acipimox-related angio-oedema during FDG-PET myocardial viability study.

Authors: Georgios Arsos; Leo Weijs; Marie de Haas; Evelyn de Vrey; John de Klerk
Journal: Eur J Nucl Med Mol Imaging Date: 2007-06-02 Impact factor: 9.236

Review 2. Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Authors: D Le Guludec; R Lautamäki; J Knuuti; J J Bax; F M Bengel
Journal: Eur J Nucl Med Mol Imaging Date: 2008-06-26 Impact factor: 9.236

Review 3. Current state of hybrid imaging: attenuation correction and fusion.

Authors: Jonathon A Nye; Tracy L Faber
Journal: J Nucl Cardiol Date: 2011-05-07 Impact factor: 5.952

4. Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors: Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal: J Nucl Cardiol Date: 2010-04 Impact factor: 5.952

5. Functional and metabolic improvement after coronary intervention for non-viable myocardium detected by ¹⁸F fluorodeoxyglucose positron emission tomography.

Authors: Kenji Fukushima; Hiroyuki Arashi; Yuichiro Minami; Risako Nakao; Michinobu Nagao; Koichiro Abe
Journal: J Cardiol Cases Date: 2019-05-03

Review 10. Metabolic imaging using PET.

Authors: Takashi Kudo
Journal: Eur J Nucl Med Mol Imaging Date: 2007-05-05 Impact factor: 9.236

PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation.

1. Intense [18F]FDG tongue uptake in a case of acipimox-related angio-oedema during FDG-PET myocardial viability study.

Review 2. Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Review 3. Current state of hybrid imaging: attenuation correction and fusion.

4. Viability assessment with MRI is superior to FDG-PET for viability: Con.

5. Functional and metabolic improvement after coronary intervention for non-viable myocardium detected by ¹⁸F fluorodeoxyglucose positron emission tomography.

6. Cine CT for attenuation correction in cardiac PET/CT.

7. Reconstruction of rapidly acquired Germanium-68 transmission scans for cardiac PET attenuation correction.

Review 8. Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient.

9. Diagnosis of myocardial viability by fluorodeoxyglucose distribution at the border zone of a low uptake region.

Review 10. Metabolic imaging using PET.

PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation.

1. Intense [18F]FDG tongue uptake in a case of acipimox-related angio-oedema during FDG-PET myocardial viability study.

Review 2. Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Review 3. Current state of hybrid imaging: attenuation correction and fusion.

4. Viability assessment with MRI is superior to FDG-PET for viability: Con.

5. Functional and metabolic improvement after coronary intervention for non-viable myocardium detected by 18F fluorodeoxyglucose positron emission tomography.

6. Cine CT for attenuation correction in cardiac PET/CT.

7. Reconstruction of rapidly acquired Germanium-68 transmission scans for cardiac PET attenuation correction.

Review 8. Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient.

9. Diagnosis of myocardial viability by fluorodeoxyglucose distribution at the border zone of a low uptake region.

Review 10. Metabolic imaging using PET.

5. Functional and metabolic improvement after coronary intervention for non-viable myocardium detected by ¹⁸F fluorodeoxyglucose positron emission tomography.